Di Zhou

Di Zhou

Auto-generated profile, based on publicly available information

Di Zhou

Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2019 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
XMXin Mou
Xin Mou
DZDi Yi Zhou
Di Yi Zhou
YLYing Hui Liu
Ying Hui Liu
KLKaiyuan Liu
Kaiyuan Liu
DZDanyang Zhou
Danyang Zhou
The aim of the present study was to identify genes under the effect of transforming growth factor‑β (TGF‑β1), high glucose (HG) and glucosamine (GlcN) in MES‑13 mesangial cells and elucidate the molecular mechanisms of diabetic nephropathy (DN). The gene expression datasets GSE2557 and GSE2558 were downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were independently screened using the GEO2R online tool. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed using the Database for Annotation, Visualization, and Integrated Discovery. The protein‑protein interaction (PPI) network was constructed using the Search Tool for the Retrieval of Interacting Genes and Cytoscape software. The hub genes were identified by the NetworkAnalyzer plugin. Overlapping genes were subjected to molecular docking analysis using SystemsDock. A total of 202 upregulated and 158 downregulated DEGs from the HG‑treated groups, 138 upregulated and 103 downregulated DEGs from the GlcN‑treated groups, and 81 upregulated and 44 downregulated DEGs from the TGF‑β1‑treated groups were identified. The majority of the DEGs were independently enriched in ‘nucleosome assembly’, ‘chromatin silencing’ and ‘xenobiotic glucuronidation’. In addition, KEGG pathways were significantly enriched in ‘systemic lupus erythematosus’, ‘protein processing in endoplasmic reticulum’ and ‘aldarate metabolism pathway’, and ‘TNF signaling pathway’ intersected in the TGF‑β1‑treated and HG‑treated groups. In total, eight hub genes, Jun, prostaglandin‑endoperoxide synthase 2 (Ptgs2), fibronectin 1 (Fn1), cyclin‑dependent kinase (Cdk)2, Fos, heat shock protein family A (Hsp70) member 5 (Hspa5), Hsp90b1 and homo sapiens hypoxia upregulated 1 (Hyou1), and three overlapping genes, Ras homolog gene family, member B (RHOB), complement factor H (CFH) and Krüppel‑like factor 15 (KLF15), were selected. Valsartan with RHOB, and fosinopril with CFH and KLF15 had preferential binding activity. In conclusion, Jun, Ptgs2, Fn1, Cdk2, Fos, Hspa5, Hsp90b1, Hyou1, RHOB, CFH and KLF15 may be potential therapeutic targets for mesangial cells associated with DN, which may provide insight into DN treatment strategies.

31 October 2019 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
PXPeipei Xu
Peipei Xu
DZDi Zhou
Di Zhou
GYGuijun Yan
Guijun Yan
JOJian Ouyang
Jian Ouyang
BCBing Chen
Bing Chen

13 March 2026 in Blood
Verified
Journal Article
Open access
YLYutong Liu
Yutong Liu
WZWenxin Zhang
Wenxin Zhang
JCJing Cai
Jing Cai
DZDi Zhou
Di Zhou
HZHongting Zhao
Hongting Zhao
KLKuanyu Li
Kuanyu Li
Erythropoiesis, the process of red blood cell production, is highly dependent on iron uptake via transferrin and its receptor, transferrin receptor 1 (TfR1), but the mechanisms governing the proper recycling of TfR1 in relation to cellular iron demands remain elusive. Here, we identify human TMEM187, a Golgi transmembrane protein of unknown function, as a novel negative regulator of erythropoiesis. Lack of TMEM187 in a cell model initiates erythropoiesis without the normal induction protocol and accelerates iron uptake. Following the induction protocol, TMEM187 ablation leads to premature erythroid maturation, resulting in early phosphatidylserine ectopia and cell membrane fragility, hallmarks of cellular senescence that renders the cells susceptible to macrophage recognition and phagocytosis. In zebrafish embryos, tmem187 deletion leads to enhanced early erythropoiesis, although the phenotype is later compensated, whereas hematopoietic stem-cell expression of human TMEM187 in mice, which lack endogenously a homologous gene, resulted in compromised erythropoiesis and moderate anemia. Mechanistically, we demonstrate that TMEM187 interacts with RAB11 to restrain endosomal recycling, interfering with RAB11-GRAB association that activates RAB11. Consequently, TMEM187 modulates TfR1 recycling to the cell membrane to fine-tune iron uptake efficiency for erythropoiesis. Our findings reveal a novel modulatory pathway in which TMEM187 plays a crucial role in regulating erythroid differentiation, maturation, and senescence, providing a previously unexplored perspective of TMEM187's physiological function.

6 October 2026 in Blood Advances
Verified
Journal Article
Open access
YXYueyi Xu
Yueyi Xu
XDXiaoqing Dong
Xiaoqing Dong
JZJunli Zhang
Junli Zhang
JWJue Wang
Jue Wang
CZCuiling Zhang
Cuiling Zhang
JOJian Ouyang
Jian Ouyang
A holistic and dynamic view of the glycomic landscape in hematological malignancies (HMs) remains poorly characterized, hindering clinical the application of glycomics in HMs. We launched a large-scale analysis of multicenter cohorts, combining retrospective (n=1,370) and prospective longitudinal (n=130) data across major HM types. We defined distinct total serum N‑glycome (TSNG) profiles for multiple myeloma, lymphoma, and acute leukemia at diagnosis, revealing shared and disease-specific signatures that support their diagnostic and subtyping potential. TSNG features changed with disease status. Key glycans decreased significantly upon complete remission and increased again at relapse. Receiver operating characteristic curve analyses demonstrated that TSNG could distinguish disease states, supporting its utility for assessing treatment response. We systematically mapped the TSNG landscape of HMs, established its clinical relevance across diagnosis, subtyping, and treatment monitoring, providing a framework for advancing the glycomics-based understanding and management of these malignancies.

6 June 2024
Verified
Preprint
Open access
DZDi Zhou
Di Zhou
QLQiqiang Long
Qiqiang Long
HCHong Chu
Hong Chu
PXPeipei Xu
Peipei Xu
YXYueyi Xu
Yueyi Xu
RZRongfu Zhou
Rongfu Zhou
Background COVID-19 is an ongoing pandemic posing a big threat to public health and economy. Novel variants are constantly emerging with different transmissibility and pathogenicity. This study aimed to explore the hematological characteristics of COVID-19 delta variant during the outbreak in July 2021, Nanjing. Methods This study retrospectively analyzed demographic and clinical parameters of 80 patients diagnosed with COVID-19 delta variant infection. Patients were classified into mild, moderate and severe/critical group according to the guideline. Characteristics of each group were compared. Results The percentage of elderly and patients with comorbidities was significantly higher in the severe/critical group. Vaccination rate was significantly lower in this group. Decreased lymphocyte number, especially CD4+ and CD8+ T cells, elevated fibrinogen, CRP, PCT and IL-6 were associated with disease severity (P<0.05). Severe or critical cases tended to have higher viral load shown by lower CT values of ORF1ab and N gene (P=0.08, P=0.06) and lower specific IgG antibody level (P=0.15) but it did not reach statistical significance. Conclusions Increasing vaccination rate in the elderly and population with comorbidities might improve the prognosis of COVID-19 delta variant. Mechanism study of immune evasion of COVID-19 and methods to booster our immune system was urgently needed.